Polymorphism in generic drug product development

Area of Science:

• Pharmaceutical Sciences
• Drug Development
• Solid-State Chemistry

Background:

• Polymorphism, the ability of a solid material to exist in multiple crystalline forms, is a critical factor in pharmaceutical development.
• Different polymorphic forms can exhibit distinct physical and chemical properties, affecting drug product performance.

Purpose of the Study:

• To discuss the influence of polymorphism on the development of generic drug products.
• To highlight the importance of selecting the appropriate polymorphic form for manufacturing bioequivalent generic medications.

Main Methods:

• Review of scientific literature on drug polymorphism and generic drug development.
• Analysis of critical quality attributes related to polymorphic control and dissolution.

Main Results:

• The selection of a specific polymorphic form is crucial for achieving bioequivalence in generic drug products.
• Effective control over the polymorphic form of the active pharmaceutical ingredient (API) is essential.
• The dissolution behavior of the final drug product is directly influenced by the drug substance's polymorphic form.

Conclusions:

• Successful generic drug product development relies on understanding and controlling drug substance polymorphism.
• Ensuring the correct polymorphic form is consistently manufactured is key to guaranteeing product quality and therapeutic equivalence.
• Dissolution testing serves as a critical measure to confirm the performance of the chosen polymorphic form.